UPMC sued Highmark and West Penn in May. In the motion, Highmark said every antitrust complaint must “at minimum make economic sense.” The payor said UPMC’s claim that it is a powerless victim of Highmark and West Penn is illogical since UPMC is a “$10 billion integrated global health enterprise” with double-digit revenue growth, according to the report.
A UPMC spokesperson could not be reached for comment in the report.
West Penn also has a three-year-old lawsuit against UPMC, claiming the health system stifled competition.
More Articles on Highmark, West Penn Allegheny Health System and UPMC:
West Penn Willing to Resume Talks with Highmark
Pittsburgh Post-Gazette: Should UPMC Be Tax-Exempt?
Highmark Unveils New Health Plan With Limited UPMC Hospitals, Physicians
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
